{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:54:01Z","timestamp":1789610041941,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejphar.2021.174040","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T17:35:18Z","timestamp":1615829718000},"page":"174040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Selective blockade of transient receptor potential vanilloid 4 reduces cyclophosphamide-induced bladder pain in mice"],"prefix":"10.1016","volume":"899","author":[{"given":"Shiori","family":"Kawasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Soga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Nanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunao","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Tsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Asaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7878-2557","authenticated-orcid":false,"given":"Yasuhide","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2021.174040_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/jpet.107.125435","article-title":"Activation of urothelial transient receptor potential vanilloid 4 by 4alpha-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat","volume":"323","author":"Birder","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174040_bib2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/01.ju.0000079766.49550.94","article-title":"Characterization of cyclophosphamide cystitis, a model of visceral and referred pain, in the mouse: species and strain differences","volume":"170","author":"Bon","year":"2003","journal-title":"J. Urol."},{"issue":"14","key":"10.1016\/j.ejphar.2021.174040_bib3","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1074\/jbc.M117.811075","article-title":"Transient receptor potential vanilloid 4 (TRPV4) activation by arachidonic acid requires protein kinase A-mediated phosphorylation","volume":"293","author":"Cao","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174040_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11255-014-0908-6","article-title":"Increased risks of healthcare-seeking behaviors of anxiety, depression and insomnia among patients with bladder pain syndrome\/interstitial cystitis: a nationwide population-based study","volume":"47","author":"Chuang","year":"2015","journal-title":"Int. Urol. Nephrol."},{"issue":"5","key":"10.1016\/j.ejphar.2021.174040_bib5","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.juro.2010.12.088","article-title":"Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis","volume":"185","author":"Evans","year":"2011","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174040_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1152\/ajprenal.00599.2009","article-title":"Functional characterization of transient receptor potential channels in mouse urothelial cells","volume":"298","author":"Everaerts","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"44","key":"10.1016\/j.ejphar.2021.174040_bib7","doi-asserted-by":"crossref","first-page":"19084","DOI":"10.1073\/pnas.1005333107","article-title":"Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis","volume":"107","author":"Everaerts","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174040_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pbiomolbio.2009.10.002","article-title":"The vanilloid transient receptor potential channel TRPV4: from structure to disease","volume":"103","author":"Everaerts","year":"2010","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"41","key":"10.1016\/j.ejphar.2021.174040_bib9","doi-asserted-by":"crossref","first-page":"27884","DOI":"10.1074\/jbc.M109.028803","article-title":"Activation of the TRPV4 ion channel is enhanced by phosphorylation","volume":"284","author":"Fan","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174040_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ejp.693","article-title":"A novel method for assessing bladder-related pain reveals the involvement of nerve growth factor in pain associated with cyclophosphamide-induced chronic cystitis in mice","volume":"20","author":"Fujita","year":"2016","journal-title":"Eur. J. Pain"},{"issue":"11","key":"10.1016\/j.ejphar.2021.174040_bib11","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1172\/JCI31766","article-title":"Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding","volume":"117","author":"Gevaert","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ejphar.2021.174040_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/GCO.0000000000000083","article-title":"Pain thresholds in women with chronic pelvic pain","volume":"26","author":"Giamberardino","year":"2014","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174040_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2010.04.010","article-title":"Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD","volume":"139","author":"Gradilone","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2021.174040_bib14","series-title":"Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) Winter Meeting","article-title":"A multicenter study evaluating the safety and efficacy of AF-219, a P2X3 antagonist, in women with interstitial cystitis\/bladder pain syndrome (IC\/BPS)","author":"Hanno","year":"2015"},{"issue":"5","key":"10.1016\/j.ejphar.2021.174040_bib15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/j.pain.0000000000001169","article-title":"Sensitization of transient receptor potential vanilloid 4 and increasing its endogenous ligand 5,6-epoxyeicosatrienoic acid in rats with monoiodoacetate-induced osteoarthritis","volume":"159","author":"Hinata","year":"2018","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.ejphar.2021.174040_bib16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.juro.2011.04.107","article-title":"The mechanoreceptor TRPV4 is localized in adherence junctions of the human bladder urothelium: a morphological study","volume":"186","author":"Janssen","year":"2011","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174040_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1464-410X.2012.11238.x","article-title":"Disability in women suffering from interstitial cystitis\/bladder pain syndrome","volume":"111","author":"Katz","year":"2013","journal-title":"BJU Int."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174040_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4196\/kjpp.2010.14.6.419","article-title":"Functional expression of TRPV4 cation channels in human mast cell line (HMC-1)","volume":"14","author":"Kim","year":"2010","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174040_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/JOE-15-0330","article-title":"Ghrelin O-acyltransferase knockout mice show resistance to obesity when fed high-sucrose diet","volume":"228","author":"Kouno","year":"2016","journal-title":"J. Endocrinol."},{"issue":"9","key":"10.1016\/j.ejphar.2021.174040_bib20","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/1440-1681.12959","article-title":"TRPV4 activates cytosolic phospholipase A2 via Ca2+ -dependent PKC\/ERK1\/2 signalling in controlling hypertensive contraction","volume":"45","author":"Li","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174040_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/00365599.2012.699100","article-title":"Bladder pain syndrome\/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells","volume":"47","author":"Logadottir","year":"2013","journal-title":"Scand J Urol"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174040_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1464-410X.1997.00097.x","article-title":"Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis","volume":"79","author":"Lowe","year":"1997","journal-title":"Br. J. Urol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174040_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/ALN.0b013e31821b1ac5","article-title":"Antagonism of nerve growth factor-TrkA signaling and the relief of pain","volume":"115","author":"Mantyh","year":"2011","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174040_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1152\/ajpregu.00008.2014","article-title":"Intravesical TRPV4 blockade reduces repeated variate stress-induced bladder dysfunction by increasing bladder capacity and decreasing voiding frequency in male rats","volume":"307","author":"Merrill","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"32","key":"10.1016\/j.ejphar.2021.174040_bib25","doi-asserted-by":"crossref","first-page":"21257","DOI":"10.1074\/jbc.M109.020206","article-title":"The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures","volume":"284","author":"Mochizuki","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2021.174040_bib26","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.juro.2010.06.005","article-title":"Interstitial cystitis\/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome","volume":"184","author":"Nickel","year":"2010","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.ejphar.2021.174040_bib27","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/j.1532-2149.2011.00096.x","article-title":"Pharmacological characterization of lysophosphatidic acid-induced pain with clinically relevant neuropathic pain drugs","volume":"16","author":"Ogawa","year":"2012","journal-title":"Eur. J. Pain"},{"issue":"2","key":"10.1016\/j.ejphar.2021.174040_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.juro.2013.01.048","article-title":"Co-cultures provide a new tool to probe communication between adult sensory neurons and urothelium","volume":"190","author":"O'Mullane","year":"2013","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.174040_bib29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/j.pain.0000000000001466","article-title":"Contribution of synovial macrophages to rat advanced osteoarthritis pain resistant to cyclooxygenase inhibitors","volume":"160","author":"Sakurai","year":"2019","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.ejphar.2021.174040_bib30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1152\/ajpregu.00367.2009","article-title":"Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function","volume":"298","author":"Schnegelsberg","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"5","key":"10.1016\/j.ejphar.2021.174040_bib31","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0022-5347(05)65726-6","article-title":"Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis","volume":"166","author":"Sun","year":"2001","journal-title":"J. Urol."},{"issue":"9","key":"10.1016\/j.ejphar.2021.174040_bib32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1464-410x.2000.00562.x","article-title":"The production of nerve growth factor by human bladder smooth muscle cells in vivo and in vitro","volume":"85","author":"Tanner","year":"2000","journal-title":"BJU Int."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174040_bib33","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.eururo.2012.05.023","article-title":"Mapping of pain phenotypes in female patients with bladder pain. Syndrome\/interstitial cystitis and controls","volume":"62","author":"Tripp","year":"2012","journal-title":"Eur. Urol."},{"issue":"7","key":"10.1016\/j.ejphar.2021.174040_bib34","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.bmc.2017.02.047","article-title":"Pharmacological evaluation of novel (6-aminopyridin-3-yl)(4-(pyridin-2-yl)piperazin-1-yl) methanone derivatives as TRPV4 antagonists for the treatment of pain","volume":"25","author":"Tsuno","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174040_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1073\/pnas.0303329101","article-title":"Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4","volume":"101","author":"Vriens","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174040_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2006.04.037","article-title":"Localization of nerve growth factor and its receptors in the human nasal mucosa","volume":"118","author":"Wu","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174040_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23736\/S0026-4806.16.04645-0","article-title":"Oxygenized low density lipoprotein down-regulates the TRPV4 protein expression of macrophage through activation of peroxisome proliferator-activated receptor \u03b3","volume":"108","author":"Xue","year":"2017","journal-title":"Minerva Med."},{"issue":"9","key":"10.1016\/j.ejphar.2021.174040_bib38","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1464-410x.2001.02190.x","article-title":"Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder","volume":"87","author":"Yiangou","year":"2001","journal-title":"BJU Int."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100193X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100193X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:51:41Z","timestamp":1757976701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992100193X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":38,"alternative-id":["S001429992100193X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174040","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective blockade of transient receptor potential vanilloid 4 reduces cyclophosphamide-induced bladder pain in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174040"}}